Data / Hiring / New York / Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. in New York, NY: 20 certified H-1B and PERM cases, FY2023 to FY2026
Oppenheimer & Co. Inc., New York, NY, had 20 certified H-1B and PERM cases in Department of Labor disclosure data, decided from November 8, 2022 to June 16, 2026: 18 H-1B labor condition applications and 2 PERM labor certifications. Its most frequent role is Research Associate, Biotechnology in New York, NY, at a median offered wage of $112,858 a year.
SpecStream is the live web data engine for teams and agents. It reads the Department of Labor's H-1B and PERM disclosure files and keeps each employer's filings by role, place and wage. Ask for your own cut (a role, a state, a list of companies) and new filings arrive in your sheet, CRM, Slack or agent.
- 13-5657518Employer ID (FEIN)
- New York, NYAddress
- 20Certified cases
- 20Positions requested
- 1Denied or withdrawn
Certified cases by fiscal year
Fiscal years run from October 1 to September 30. The latest year covers decisions through June 16, 2026.
| Fiscal year | H-1B | PERM | Positions | Median offered wage |
|---|---|---|---|---|
| FY2023 | 7 | 0 | 7 | $106,000 |
| FY2024 | 7 | 0 | 7 | $113,000 |
| FY2025 | 3 | 1 | 4 | $112,866 |
| FY2026 | 1 | 1 | 2 | $144,643 |
Roles certified
Cases with the same job title, occupation code and worksite are grouped. Offered wage is the wage the employer filed; the range leaves out the lowest and highest 5% when a group has 20 cases or more. The prevailing wage is the one the employer filed against. A blank worksite means the file does not give one.
| Job title | Occupation | Worksite | Cases | Years | Median offered | Offered range | Median prevailing | Wage level | Program | Latest decision | Latest case number | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research Associate, Biotechnology | 13-2051 Financial and Investment Analysts | New York, NY | 3 | FY2023 to FY2026 | $115,731 | $112,715 to $160,000 | $115,731 | II | H-1B | June 16, 2026 | I-200-25148-025959 | dol.gov |
| Director, Equity Research | 13-2051 Financial and Investment Analysts | New York, NY | 2 | FY2024 to FY2025 | $114,366 | $113,000 to $160,000 | $114,223 | II | H-1B | June 25, 2025 | I-200-25168-101370 | dol.gov |
| Investment Banking Analyst | 13-2051 Financial and Investment Analysts | New York, NY | 2 | FY2023 | $95,000 | $95,000 to $110,000 | $85,946 | I | H-1B | September 19, 2023 | I-200-23255-339235 | dol.gov |
| Investment Banking Associate | 13-2051 Financial and Investment Analysts | New York, NY | 2 | FY2023 to FY2024 | $155,000 | $150,000 to $175,000 | $138,248 | III | H-1B | October 25, 2023 | I-200-23291-441244 | dol.gov |
| ="Analyst" | Financial and Investment Analysts | New York, NY | 1 | FY2025 | $95,000 | $95,000 to $115,000 | $85,301 | I | H-1B | February 6, 2025 | I-200-25030-653177 | dol.gov |
| AML Testing & Model Validation Analyst | 13-2099 Financial Quantitative Analysts | New York, NY | 1 | FY2024 | $88,700 | $88,700 to $100,000 | $88,670 | II | H-1B | June 18, 2024 | I-200-24163-095127 | dol.gov |
| Associate Director | 13-2051 Financial and Investment Analysts | New York, NY | 1 | FY2025 | $110,000 | $110,000 to $135,000 | Not listed | PERM | March 4, 2025 | G-100-23282-419054 | dol.gov | |
| Associate – Financial Planning | 13-2051 Financial and Investment Analysts | New York, NY | 1 | FY2023 | $80,000 | $80,000 to $95,000 | $77,272 | I | H-1B | September 14, 2023 | I-203-23065-825660 | dol.gov |
| Associate, Equity Research | 13-2051 Financial and Investment Analysts | New York, NY | 1 | FY2023 | $106,000 | $106,000 to $121,000 | $105,331 | II | H-1B | May 23, 2023 | I-200-23136-024233 | dol.gov |
| Associate, Healthcare Investment Banking | 13-2051 Financial and Investment Analysts | New York, NY | 1 | FY2024 | $155,000 | $155,000 to $170,000 | $112,715 | II | H-1B | May 21, 2024 | I-200-24135-992625 | dol.gov |
| Counsel | 23-1011 Lawyers | New York, NY | 1 | FY2025 | $158,000 | $158,000 to $168,000 | $156,832 | II | H-1B | August 22, 2025 | I-200-25227-245546 | dol.gov |
| Director, Biotechnology | 13-2051 Financial and Investment Analysts | New York, NY | 1 | FY2026 | $173,555 | $173,555 to $200,555 | Not listed | PERM | February 4, 2026 | G-100-24262-346492 | dol.gov | |
| Equity Research Associate, Exchanges & Information Analytics | 13-2051 Financial and Investment Analysts | New York, NY | 1 | FY2024 | $100,000 | $100,000 to $120,000 | $82,285 | I | H-1B | May 16, 2024 | I-200-24130-976828 | dol.gov |
| Equity Research Associate, Portfolio & Electronic Trading | 13-2051 Financial and Investment Analysts | New York, NY | 1 | FY2024 | $83,000 | $83,000 to $95,000 | $82,285 | I | H-1B | May 16, 2024 | I-200-24130-976752 | dol.gov |
| Executive Director, Equity Research | 13-2051 Financial and Investment Analysts | New York City, NY | 1 | FY2023 | $161,429 | $161,429 to $170,000 | $161,429 | IV | H-1B | February 20, 2023 | I-200-23044-769675 | dol.gov |
Worksite states
| State | Cases |
|---|---|
| New York | 20 |
Also on SpecStream
- Every company hiring Financial and Investment Analysts in New York
- Every company hiring Financial Quantitative Analysts in New York
- Every company hiring Lawyers in New York
Updated June 16, 2026. Read from US Department of Labor, Office of Foreign Labor Certification. Public domain (U.S. government work). A certified labor condition application (H-1B, H-1B1, E-3) or PERM labor certification is an employer filing the Department of Labor approved. It is not a count of people hired or visas issued. Wages are as the employer filed them, converted to a yearly figure at 2,080 hours; a wage whose unit is missing is left blank. The files show the first worksite of a case. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.